Cited by 218Brain Metastases and TreatmentGlioma Diagnosis and TreatmentCancer Cells and Metastasis

Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization

Open access
Fitzgerald, Daniel P., Palmieri, Diane, Hua, Emily, Hargrave, Elizabeth, Herring, Jeanne M., Qian, Yongzhen, Vega-Valle, Eleazar, Weil, Robert J. +3 more·2008·Clinical & Experimental Metastasis

Abstract

Interactions between tumor cells and the microenvironment are crucial to tumor formation and metastasis. The central nervous system serves as a "sanctuary" site for metastasis, resulting in poor prognosis in diagnosed patients. The incidence of brain metastasis is increasing; however, little is known about interactions between the brain and metastatic cells. Brain pathology was examined in an experimental model system of brain metastasis, using a subline of MDA-MB-231 human breast cancer cells. The results were compared with an analysis of sixteen resected human brain metastases of breast cancer. Experimental metastases formed preferentially in specific brain regions, with a distribution similar to clinical cases. In both the 231-BR model, and in human specimens, Ki67 expression indicated that metastases were highly proliferative (approximately 50%). Little apoptosis was observed in either set of tumors. In the model system, metastases elicited a brain inflammatory response, with extensive reactive gliosis surrounding metastases. Similarly, large numbers of glial cells were found within the inner tumor mass of human brain metastases. In vitro co-cultures demonstrated that glia induced a approximately 5-fold increase in metastatic cell proliferation (P<0.001), suggesting that brain tissue secretes factors conducive to tumor cell growth. Molecules used to signal between tumor cells and the surrounding glia could provide a new avenue of therapeutic targets for brain metastases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10585-008-9193-z

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cancer cells communicate with their microenvironment, specifically with organ-specific cells, resulting in organ-selectivity in metastasis.

    “This is particularly important as there is growing evidence that cancer cells communicate with their microenvironment[29], specifically with organ-specific cells[30], resulting in organ-selectivity in metastasis[31].”

    From Microfluidics: A New Tool for Modeling Cancer–Immune Interactions (2016) · cites this paper as [30]

    The Introduction (page unavailable) invokes the seed-and-soil hypothesis to explain why tumors metastasize to particular organs. The Discussion (page unavailable) supports a narrower finding: breast cancer cells alter the brain microenvironment, which contributes to metastatic progression. The paper does not establish that communication with organ-specific cells causes organ selectivity across metastases. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fitzgerald, D. P., Palmieri, D., Hua, E., Hargrave, E., Herring, J. M., Qian, Y., Vega-Valle, E., Weil, R. J., Stark, A. M., Vortmeyer, A. O., & Steeg, P. S.
Affiliations
  • National Institutes of Health (US)
  • Cleveland Clinic (US)
  • University Hospital Schleswig-Holstein (DE)
Corresponding author
Fitzgerald, Daniel P.
Venue
Clinical & Experimental Metastasis
Published
2008-07-23
Volume
25
Issue
7
Pages
799-810
ISSN
  • 0262-0898 (ISSN-L)
  • 1573-7276
OpenAlex
W2008508879
Cited by
218
References
54
Citations by year
2026: 10 · 2025: 7 · 2024: 11 · 2023: 14 · 2022: 9 · 2021: 15 · 2020: 9 · 2019: 10 · 2018: 5 · 2017: 11 · 2016: 22 · 2015: 19 · 2014: 12 · 2013: 20 · 2012: 13
FWCI
9.49
Type
journal article
Language
en
Open access
Locations
  • Clinical & Experimental Metastasis (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (Z01BC010538)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Brain Metastases and Treatment
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
brain metastases, breast cancer, reactive gliosis, tumor microenvironment, MDA-MB-231 cells, Ki-67 proliferation index, neuroinflammation, tumor cell proliferation, co-culture, tumor colonization, therapeutic target
MeSH terms
Adult, Aged, Animals, Brain Neoplasms, Breast Neoplasms, Cell Movement, Female, Humans, Mice, Inbred BALB C, Middle Aged, Neuroglia, Apoptosis, Leukocyte Common Antigens, CD11b Antigen, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review